FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056514455> ?p ?o ?g. }

• W2056514455 endingPage "69" @default.
• W2056514455 startingPage "63" @default.
• W2056514455 abstract "To investigate current status of diagnosis and treatment of bladder cancer in China. A database was generated by Chinese Bladder Cancer Consortium (CBCC). From January 2007 to December 2012, 14,260 cases from 44 CBCC centers were included. Data of diagnosis, treatment and pathology were collected. The average age was 63.5 year-old and most patients were male (84.3%). The most common histologic types were urothelial carcinoma (91.4%), adenocarcinoma (1.8%), and squamous carcinoma (1.9%). According to 1973 and 2004 WHO grading system, 42.0%, 41.0%, and 17.0% of patients were grade 1, 2, and 3, and 16.0%, 48.7%, and 35.3% of patients were papillary urothelial neoplasms of low malignant potential, low, and high grade, respectively. Non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC) were 25.2% and 74.1%, respectively (0.8% not clear). Carcinoma in situ was only 2.4%. Most patients were diagnosed by white-light cystoscopy with biopsy (74.3%). Fluorescence and narrow band imaging cystoscopy had additional detection rate of 1.0% and 4.0%, respectively. Diagnostic transurethral resection (TUR) provided detection rate of 16.9%. Most NMIBCs were treated with TUR (89.2%). After initial TUR, 2.6% accepted second TUR, and 45.7%, 69.9%, and 58.7% accepted immediate, induced, and maintenance chemotherapy instillation, respectively. Most MIBCs were treated with radical cystectomy (RC, 59.7%). Laparoscopic RCs were 35.1%, while open RC 63.4%. Extended and standard pelvic lymph node dissection were 7% and 66%, respectively. Three most common urinary diversions were orthotopic neobladder (44%), ileal conduit (31%), and ureterocutaneostomy (23%). Only 2.3% of patients accepted neo-adjuvant chemotherapy and only 18% of T3 and T4 patients accepted adjuvant chemotherapy. Disease characteristics are similar to international reports, while differences of diagnosis and treatment exist. This study can provide evidences for revisions of the guideline on bladder cancer in China." @default.
• W2056514455 created "2016-06-24" @default.
• W2056514455 creator A5000432967 @default.
• W2056514455 creator A5002725780 @default.
• W2056514455 creator A5003905939 @default.
• W2056514455 creator A5004092065 @default.
• W2056514455 creator A5005495118 @default.
• W2056514455 creator A5006621039 @default.
• W2056514455 creator A5010806417 @default.
• W2056514455 creator A5011378633 @default.
• W2056514455 creator A5014028086 @default.
• W2056514455 creator A5014944426 @default.
• W2056514455 creator A5015069780 @default.
• W2056514455 creator A5016222525 @default.
• W2056514455 creator A5016243869 @default.
• W2056514455 creator A5017694336 @default.
• W2056514455 creator A5018465248 @default.
• W2056514455 creator A5019014290 @default.
• W2056514455 creator A5019828141 @default.
• W2056514455 creator A5020558192 @default.
• W2056514455 creator A5021044404 @default.
• W2056514455 creator A5021384155 @default.
• W2056514455 creator A5022016255 @default.
• W2056514455 creator A5022585660 @default.
• W2056514455 creator A5022746945 @default.
• W2056514455 creator A5022814916 @default.
• W2056514455 creator A5022989187 @default.
• W2056514455 creator A5023868415 @default.
• W2056514455 creator A5028607228 @default.
• W2056514455 creator A5031103557 @default.
• W2056514455 creator A5032437498 @default.
• W2056514455 creator A5032857124 @default.
• W2056514455 creator A5033040107 @default.
• W2056514455 creator A5036641266 @default.
• W2056514455 creator A5037515729 @default.
• W2056514455 creator A5037564237 @default.
• W2056514455 creator A5038951834 @default.
• W2056514455 creator A5038961059 @default.
• W2056514455 creator A5041100767 @default.
• W2056514455 creator A5041466556 @default.
• W2056514455 creator A5041932034 @default.
• W2056514455 creator A5042003685 @default.
• W2056514455 creator A5042665914 @default.
• W2056514455 creator A5043155449 @default.
• W2056514455 creator A5043519261 @default.
• W2056514455 creator A5044513573 @default.
• W2056514455 creator A5045169479 @default.
• W2056514455 creator A5049787568 @default.
• W2056514455 creator A5049897355 @default.
• W2056514455 creator A5054215153 @default.
• W2056514455 creator A5054412242 @default.
• W2056514455 creator A5054836092 @default.
• W2056514455 creator A5055022403 @default.
• W2056514455 creator A5056930997 @default.
• W2056514455 creator A5056952779 @default.
• W2056514455 creator A5057056291 @default.
• W2056514455 creator A5060187332 @default.
• W2056514455 creator A5062284808 @default.
• W2056514455 creator A5062442083 @default.
• W2056514455 creator A5063224443 @default.
• W2056514455 creator A5063265167 @default.
• W2056514455 creator A5063815351 @default.
• W2056514455 creator A5065771969 @default.
• W2056514455 creator A5066245033 @default.
• W2056514455 creator A5067078308 @default.
• W2056514455 creator A5068840589 @default.
• W2056514455 creator A5069024607 @default.
• W2056514455 creator A5069417259 @default.
• W2056514455 creator A5070046055 @default.
• W2056514455 creator A5070855749 @default.
• W2056514455 creator A5072249624 @default.
• W2056514455 creator A5074024312 @default.
• W2056514455 creator A5074281836 @default.
• W2056514455 creator A5075289285 @default.
• W2056514455 creator A5077353181 @default.
• W2056514455 creator A5078658507 @default.
• W2056514455 creator A5079186859 @default.
• W2056514455 creator A5079667206 @default.
• W2056514455 creator A5079886307 @default.
• W2056514455 creator A5080034477 @default.
• W2056514455 creator A5080568314 @default.
• W2056514455 creator A5081288331 @default.
• W2056514455 creator A5083417334 @default.
• W2056514455 creator A5083602758 @default.
• W2056514455 creator A5084763638 @default.
• W2056514455 creator A5085220000 @default.
• W2056514455 creator A5085712319 @default.
• W2056514455 creator A5087920560 @default.
• W2056514455 creator A5088780514 @default.
• W2056514455 creator A5090114231 @default.
• W2056514455 creator A5090416648 @default.
• W2056514455 date "2015-04-01" @default.
• W2056514455 modified "2023-10-14" @default.
• W2056514455 title "Current status of diagnosis and treatment of bladder cancer in China – Analyses of Chinese Bladder Cancer Consortium database" @default.
• W2056514455 cites W1571190881 @default.
• W2056514455 cites W1976576040 @default.
• W2056514455 cites W2001899785 @default.
• W2056514455 cites W2028129449 @default.

• next